127 related articles for article (PubMed ID: 25999720)
1. Profile of agomelatine and its potential in the treatment of generalized anxiety disorder.
Levitan MN; Papelbaum M; Nardi AE
Neuropsychiatr Dis Treat; 2015; 11():1149-55. PubMed ID: 25999720
[TBL] [Abstract][Full Text] [Related]
2. Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action.
Millan MJ
Ther Adv Psychopharmacol; 2022; 12():20451253221105128. PubMed ID: 35795687
[TBL] [Abstract][Full Text] [Related]
3. Agomelatine in treating generalized anxiety disorder.
Demyttenaere K
Expert Opin Investig Drugs; 2014 Jun; 23(6):857-64. PubMed ID: 24766542
[TBL] [Abstract][Full Text] [Related]
4. Agomelatine for the treatment of generalized anxiety disorder.
Buoli M; Grassi S; Serati M; Altamura AC
Expert Opin Pharmacother; 2017 Sep; 18(13):1373-1379. PubMed ID: 28730851
[TBL] [Abstract][Full Text] [Related]
5. Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis.
Wang SM; Woo YS; Kim NY; Na HR; Lim HK; Bahk WM
Clin Psychopharmacol Neurosci; 2020 Aug; 18(3):423-433. PubMed ID: 32702221
[TBL] [Abstract][Full Text] [Related]
6. Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine.
Stein DJ
Adv Ther; 2021 Sep; 38(Suppl 2):52-60. PubMed ID: 34417992
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of agomelatine in the treatment of depression.
Plesničar BK
Patient Prefer Adherence; 2014; 8():603-12. PubMed ID: 24833894
[TBL] [Abstract][Full Text] [Related]
8. A review of preliminary observations on agomelatine in the treatment of anxiety disorders.
Levitan MN; Papelbaum M; Nardi AE
Exp Clin Psychopharmacol; 2012 Dec; 20(6):504-9. PubMed ID: 23088208
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and network meta-analysis of agomelatine for the treatment of generalized anxiety disorder in adult patients.
Hood SD; Odufowora-Sita O; Briere JB; Lucchino M; Khrouf F; Olewinska E; Pierzchala P; Mezghani M; Nikodem M; Lévy P
Int Clin Psychopharmacol; 2024 May; ():. PubMed ID: 38804215
[TBL] [Abstract][Full Text] [Related]
10. Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.
Howland RH
Neuropsychiatr Dis Treat; 2009; 5():563-76. PubMed ID: 19966905
[TBL] [Abstract][Full Text] [Related]
11. A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.
Fornaro M; Prestia D; Colicchio S; Perugi G
Curr Neuropharmacol; 2010 Sep; 8(3):287-304. PubMed ID: 21358978
[TBL] [Abstract][Full Text] [Related]
12. Agomelatine for Depression in Schizophrenia: A Case-Series.
Mutschler J; Rüsch N; Schönfelder H; Herwig U; Brühl AB; Grosshans M; Rössler W; Russmann H
Psychopharmacol Bull; 2012 Feb; 45(1):35-43. PubMed ID: 27738367
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder.
Buoli M; Mauri MC; Altamura AC
Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):885-92. PubMed ID: 24717138
[TBL] [Abstract][Full Text] [Related]
14. Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations.
Sonmez AI; Almorsy A; Ramsey LB; Strawn JR; Croarkin PE
Depress Anxiety; 2020 Aug; 37(8):747-759. PubMed ID: 32419335
[TBL] [Abstract][Full Text] [Related]
15. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
17. New approaches to the pharmacological management of generalized anxiety disorder.
Buoli M; Caldiroli A; Caletti E; Paoli RA; Altamura AC
Expert Opin Pharmacother; 2013 Feb; 14(2):175-84. PubMed ID: 23282069
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Pharmacological Treatments of Anxiety Disorders: An Updated Systematic Review.
Perna G; Alciati A; Riva A; Micieli W; Caldirola D
Curr Psychiatry Rep; 2016 Mar; 18(3):23. PubMed ID: 26830881
[TBL] [Abstract][Full Text] [Related]
19. Generalized anxiety disorder: how to treat, and for how long?
Lam RW
Int J Psychiatry Clin Pract; 2006; 10 Suppl 1():10-5. PubMed ID: 24931538
[TBL] [Abstract][Full Text] [Related]
20. Long-term chamomile (Matricaria chamomilla L.) treatment for generalized anxiety disorder: A randomized clinical trial.
Mao JJ; Xie SX; Keefe JR; Soeller I; Li QS; Amsterdam JD
Phytomedicine; 2016 Dec; 23(14):1735-1742. PubMed ID: 27912875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
